Rising prevalence of lifestyle diseases and related health concerns will help the Russian pharmaceutical industry grow at a CAGR of 13% during 2011-2013, says RNCOS.

Noida, UP -- (SBWire) -- 03/31/2011 -- According to our latest research offering “Russian Pharma Sector Forecast to 2013”, rising prevalence of lifestyle disease will help the Russian pharmaceutical industry to grow at a stupendous CAGR of around 13% during 2011-2013. Increasing incidence of diseases, such as diabetes, hypertension, cardiovascular disorders, etc., will cause a great surge in the demand of pharma products in the country. Besides health concerns of the population, the industry will feed off the various new reforms being introduced by the Russian government for the growth of the domestic industry. These measures are the result of long standing dependence of Russia on imported pharma products, resulting into increased healthcare expenditure.

The industry will also receive a boost from the increasing foreign investments as the government wants pharma players to establish their manufacturing units in Russia. Considering the healthcare costs in the country, healthcare spending in the country will increase by the enforcement of obligatory health insurance schemes. This will have a direct impact on the pharma industry.

Additionally, rising investments will cause a surge in the commercial drugs segment, which is expected to occupy the largest market share by 2013.

Our team of experienced industry experts have given due consideration to the impact of the recession while estimating and forecasting of market data. Moreover, the report contains a detail overview of the market’s potential and the future growth prospects. Besides market drivers, our report covers the prominent roadblocks that are being faced by the Russian pharma industry.

Moreover, our report “Russian Pharma Sector Forecast to 2013” provides prudent analysis of authentic data, which has been procured through extensive research. The report also provides information regarding the leading drugs, segment-wise break up, and information on major therapy areas in the market. Additionally, the report discusses the latest industrial developments and competitive landscape to help clients understand the market structure and its progress in coming years.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM243.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm

About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.